Chemical proteomics-driven discovery of oleocanthal as an Hsp90 inhibitor

Luigi Margarucci, Maria Chiara Monti, Chiara Cassiano, Matteo Mozzicafreddo, Mauro Angeletti, Raffaele Riccio, Alessandra Tosco, Agostino Casapullo

Chemical Communications · 2013 · 51 citations · 22 references

Concepts

Abstract

Hsp90, a key target in cancer therapy, has been identified as the main partner of oleocanthal, an olive oil bioactive compound. A combination of chemical and biological assays disclosed its mechanism of action at the molecular level.

References

22